MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/medsci14030371

Медицинская библиотека · Medical sciences (Basel, Switzerland) · 2026

Morin Attenuates Hyperglycemia and Metabolic Dysregulation in Ovariectomized Diabetic Mouse Model.

Espinosa-Juárez Josué Vidal, Orantes-Sánchez Viridiana, Gómez-Morga Joaquín, de la Torre-Sosa Citlaly Natali, Briones-Aranda Alfredo, Jaramillo-Morales Osmar Antonio, Corzo-Gómez Josselin Carolina, Cruz-Trujillo Refugio, Cruz-Cadena Raúl, Gómez Pliego Raquel

СтатьяПеревод пока не подготовлен

Аннотация

Background/

Objectives

Estrogen deficiency is associated with metabolic disturbances and impaired glucose homeostasis. Morin, a natural flavonol, has shown promising hypoglycemic and antioxidant properties, but its effects under hypoestrogenic diabetic conditions remain poorly understood. The aim of this study was to evaluate the effects of morin on body weight, fasting blood glucose, glucose tolerance, and selected serum biochemical markers in an experimental model of diabetes under estrogen-deficient conditions (ovariectomized diabetic female mice).

Methods

Female CD1 mice underwent sham surgery or ovariectomy (OVX), and each surgical condition was further divided into non-diabetic and diabetic subgroups treated with vehicle, glibenclamide (10 mg/kg), or morin (30 mg/kg). Body weight and fasting blood glucose were monitored over a 15-day treatment period. Oral glucose tolerance was assessed on day 15, and serum biochemical markers, including glucose, cholesterol, triglycerides, uric acid, blood urea nitrogen, creatinine, ALT, and AST, were measured thereafter.

Results

Ovariectomy aggravated diabetes-associated hyperglycemia, impaired glucose tolerance, and triglyceride elevation. Morin treatment reduced fasting blood glucose and improved glucose tolerance in diabetic mice, including ovariectomized animals. Morin also attenuated the increase in serum triglycerides and blood urea nitrogen in ovariectomized diabetic mice, although it did not significantly improve cholesterol, uric acid, creatinine, ALT, or AST levels. Compared with glibenclamide, morin showed relevant glucose-lowering activity but had a more limited effect on the overall biochemical profile.

Conclusions

These findings suggest that morin may partially improve glycemic control and selected metabolic alterations in experimental diabetes associated with estrogen deficiency. Further studies are required to clarify its mechanisms of action, long-term efficacy, and translational relevance.

Для цитирования: Espinosa-Juárez Josué Vidal, Orantes-Sánchez Viridiana, Gómez-Morga Joaquín, de la Torre-Sosa Citlaly Natali, Briones-Aranda Alfredo, Jaramillo-Morales Osmar Antonio, Corzo-Gómez Josselin Carolina, Cruz-Trujillo Refugio, Cruz-Cadena Raúl, Gómez Pliego Raquel. Morin Attenuates Hyperglycemia and Metabolic Dysregulation in Ovariectomized Diabetic Mouse Model.. Medical sciences (Basel, Switzerland). 2026. DOI: 10.3390/medsci14030371.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.